Richard Larson

51PUBLICATIONS

271CO-AUTHORS

NeonatologyGene expression (incl. microarray and other genome-wide approaches)Haematological tumoursGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (51)

Sort by Publication Date:

|May 08, 2026

Long-term Follow-up of a Pediatric Regimen for AYA with Ph-negative ALL: 10-year Survival of CALGB 10403 (Alliance).

|Jan 29, 2026

Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences the risk of acute myeloid leukemia.

Diyanath Ranasinghe, Wei-Yu Lin, Sarah E Fordham

|Dec 15, 2025

Asciminib demonstrates superior efficacy and safety in newly diagnosed chronic myeloid leukemia in the ASC4FIRST trial.

Jorge E Cortes, Timothy P Hughes, Jianxiang Wang

|Oct 27, 2025

Outcomes of patients with relapsed/refractory acute leukaemia treated with revumenib with a focus on post-revumenib therapies.

Miles Thomas, Hannah Johnston, Emily Dworkin

|Aug 14, 2025

Clinical and molecular characterization of TP53-mutant acute lymphoblastic leukemia in adults.

Ethan J Harris, Diren Arda Karaoglu, Madina Sukhanova

|Jul 11, 2025

2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia.

Jane F Apperley, Dragana Milojkovic, Nicholas C P Cross

Pageof 9

Frequent Collaborators

Mark R Litzow

Hartmut Döhner

Andrew H Wei

Anand Ashwin Patel

Krzysztof Mrózek

Maria Teresa Voso

Anjali S Advani

Hagop M Kantarjian

Miguel A Sanz

Dietger Niederwieser

Frequent Collaborators

Mark R Litzow

Hartmut Döhner

Andrew H Wei

Anand Ashwin Patel